- Home
- CZNC vs JSPR Comparison
CZNC vs JSPR Comparison
Compare CZNC & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- JSPR
- Stock Information
- Founded
- CZNC 1864
- JSPR 2018
- Country
- CZNC United States
- JSPR United States
- Employees
- CZNC N/A
- JSPR N/A
- Industry
- CZNC Major Banks
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CZNC Finance
- JSPR Health Care
- Exchange
- CZNC Nasdaq
- JSPR Nasdaq
- Market Cap
- CZNC 315.7M
- JSPR 325.7M
- IPO Year
- CZNC N/A
- JSPR N/A
- Fundamental
- Price
- CZNC $18.78
- JSPR $22.50
- Analyst Decision
- CZNC
- JSPR Strong Buy
- Analyst Count
- CZNC 0
- JSPR 11
- Target Price
- CZNC N/A
- JSPR $73.38
- AVG Volume (30 Days)
- CZNC 33.2K
- JSPR 176.2K
- Earning Date
- CZNC 10-17-2024
- JSPR 11-07-2024
- Dividend Yield
- CZNC 6.01%
- JSPR N/A
- EPS Growth
- CZNC N/A
- JSPR N/A
- EPS
- CZNC 1.44
- JSPR N/A
- Revenue
- CZNC $101,899,000.00
- JSPR N/A
- Revenue This Year
- CZNC N/A
- JSPR N/A
- Revenue Next Year
- CZNC $7.24
- JSPR N/A
- P/E Ratio
- CZNC $12.97
- JSPR N/A
- Revenue Growth
- CZNC N/A
- JSPR N/A
- 52 Week Low
- CZNC $16.50
- JSPR $6.20
- 52 Week High
- CZNC $22.93
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- CZNC 36.43
- JSPR 53.62
- Support Level
- CZNC $18.33
- JSPR $20.77
- Resistance Level
- CZNC $19.92
- JSPR $23.11
- Average True Range (ATR)
- CZNC 0.53
- JSPR 1.59
- MACD
- CZNC -0.18
- JSPR -0.01
- Stochastic Oscillator
- CZNC 17.18
- JSPR 68.97
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.